PL2214699T3 - Sposób, kompozycja i wyrób do dostarczania alfa1-antytrypsyny - Google Patents

Sposób, kompozycja i wyrób do dostarczania alfa1-antytrypsyny

Info

Publication number
PL2214699T3
PL2214699T3 PL08845718T PL08845718T PL2214699T3 PL 2214699 T3 PL2214699 T3 PL 2214699T3 PL 08845718 T PL08845718 T PL 08845718T PL 08845718 T PL08845718 T PL 08845718T PL 2214699 T3 PL2214699 T3 PL 2214699T3
Authority
PL
Poland
Prior art keywords
antitrypsin
article
manufacture
composition
providing alpha
Prior art date
Application number
PL08845718T
Other languages
English (en)
Inventor
Vikram Arora
Mohan Pamarthi
Philip Scuderi
Original Assignee
Grifols Therapeutics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40591766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2214699(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Therapeutics Inc. filed Critical Grifols Therapeutics Inc.
Publication of PL2214699T3 publication Critical patent/PL2214699T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL08845718T 2007-11-02 2008-10-31 Sposób, kompozycja i wyrób do dostarczania alfa1-antytrypsyny PL2214699T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98497507P 2007-11-02 2007-11-02

Publications (1)

Publication Number Publication Date
PL2214699T3 true PL2214699T3 (pl) 2017-05-31

Family

ID=40591766

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08845718T PL2214699T3 (pl) 2007-11-02 2008-10-31 Sposób, kompozycja i wyrób do dostarczania alfa1-antytrypsyny

Country Status (9)

Country Link
US (3) US20110002909A1 (pl)
EP (1) EP2214699B1 (pl)
CA (1) CA2703393C (pl)
ES (1) ES2611944T3 (pl)
HU (1) HUE030205T2 (pl)
NZ (1) NZ584766A (pl)
PL (1) PL2214699T3 (pl)
PT (1) PT2214699T (pl)
WO (1) WO2009059082A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2332645B1 (es) 2009-06-30 2010-10-18 Grifols, S.A. Utilizacion de alfa-1-antitripsina para la preparacion de medicamentos para el tratamiento del sindrome de fatiga cronica.
CA2905471A1 (en) * 2013-03-15 2014-09-25 Conformis, Inc. Posterior-stabilized knee implant components and instruments
EP2978442B1 (en) * 2013-03-29 2020-03-18 The Regents of the University of Colorado, a body corporate Alpha 1 antitrypsin of use for preparing a subject for transplant
IL267923B2 (en) 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366894A (en) * 1986-06-30 1994-11-22 Pharmaceutical Proteins Limited Peptide production
US5093316A (en) * 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
ATE254939T1 (de) 1993-07-31 2003-12-15 Aradigm Corp Nadelloser injektor
GB9504878D0 (en) 1995-03-10 1995-04-26 Weston Medical Ltd Viscously coupled actuator
US5730723A (en) * 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AU3511500A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
PT1343809E (pt) * 2000-12-14 2015-09-22 Grifols Therapeutics Inc Método de preparação de inibidor de proteinase alfa-1
US7247704B2 (en) * 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
KR101025707B1 (ko) * 2002-11-23 2011-03-30 재단법인서울대학교산학협력재단 사람 알파1-안티트립신을 생산하는 형질전환 복제소 및이것의 생산 방법
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
RS20060077A (en) 2003-08-12 2008-08-07 Octapharma Ag., Process for preparing an alpha-1-antitrypsin solution
WO2005047323A1 (en) * 2003-11-10 2005-05-26 Arriva-Prometic Inc. Dry recombinant human alpha 1-antitrypsin formulation

Also Published As

Publication number Publication date
EP2214699A4 (en) 2010-12-22
US20240092868A1 (en) 2024-03-21
US20110002909A1 (en) 2011-01-06
EP2214699A2 (en) 2010-08-11
ES2611944T3 (es) 2017-05-11
CA2703393C (en) 2018-07-24
WO2009059082A3 (en) 2009-06-18
US20200172599A1 (en) 2020-06-04
WO2009059082A2 (en) 2009-05-07
NZ584766A (en) 2012-12-21
AU2008318587A1 (en) 2009-05-07
EP2214699B1 (en) 2016-11-30
HUE030205T2 (en) 2017-05-29
PT2214699T (pt) 2017-01-10
CA2703393A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
EP2130435B8 (en) Agent for improving alkali resistance of plant and method for improving alkali resistance of plant
EP2035519A4 (en) ADHESIVE COMPOSITIONS, ADHESIVE ARTICLES, AND METHODS OF MAKING SAME
DE602007014118D1 (de) Polyethylenzusammensetzungen, herstellungsverfahren dafür und gegenstände daraus
DE602007006977D1 (de) Polyethylenzusammensetzungen, herstellungsverfahren dafür und gegenstände daraus
IL193746A (en) Antimicrobial and catheter preparations containing them and methods for their preparation
PL2219497T3 (pl) Materiał kompozytowy, sposób jego wytwarzania i wyroby wytworzone w ten sposób
EP2221346A4 (en) MOLDING COMPOSITION CONTAINING GLASS AND METHOD FOR PRODUCING THE SAME
IL205823A0 (en) Article and method of manufacturing same
EP2166026A4 (en) PROCESS FOR PRODUCTION OF HYDROFUGE / OLEOVE COMPOSITION AND ARTICLE USING THE SAME
EP2103590A4 (en) METHOD FOR PRODUCING AN ACROLEINE AND GLYCERINE-CONTAINING COMPOSITION
PL2054128T3 (pl) Kompozycja materiałów i sposób jej wytwarzania
GB2475440B (en) Antimicrobial agent and method for the production thereof
WO2008060795A3 (en) Antimicrobial articles and method of manufacture
EP2471883A4 (en) WATER-BASED ADHESIVE COMPOSITION, PROCESS FOR PRODUCING THE SAME, AND ADHESIVE FILM
PL2367424T3 (pl) Kompozycja do zwalczania chorób roślin oraz sposób zwalczania chorób roślin
ZA201002321B (en) Braze-metal coated articles and process for making same
EP2141178A4 (en) PROCESS FOR PRODUCING ANTITHROMBIN COMPOSITION
ZA201103798B (en) Composition for controlling plant diseases and method for controlling plant diseases
ZA200806434B (en) Calcium-enrichment compositions and methods for production thereof
IL219485A0 (en) Composition, method, and kit for alpha-1 proteinase inhibitor
ZA201103412B (en) Composition and method for controlling plant diseases
PT2214699T (pt) Método, composição e artigo de fabrico para proporcionar alfa-1 antitripsina
WO2008021135A8 (en) Syneretic composition, associated method and article
GB2435262B (en) Method, composition and articles
EP2206751A4 (en) Dyeing Composition, Method for Preparing and Dyeing Method